Assesment of the Efficacy of Personalized Parent-child Psychotherapy in Children Under 3 Years Old
ECRIN
1 other identifier
interventional
234
1 country
4
Brief Summary
This study aims to assess the efficacy at 4 months of a personalized strategy comparatively to a standard Psychodynamic Integrative Therapy, on childrens' symptom improvment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2022
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2022
CompletedFirst Posted
Study publicly available on registry
January 25, 2022
CompletedStudy Start
First participant enrolled
February 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
September 19, 2024
September 1, 2024
4.4 years
January 10, 2022
September 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Efficacy of therapy
To assess the efficacy at 4 months of a personalized strategy by Interactive Guidance or Psychodynamic Therapy, comparatively to a standard Psychodynamic Therapy, on child symptoms assessed with the "Symptom Check List"
Month 4
Study Arms (2)
Standard care group
ACTIVE COMPARATORStandard psychodynamic therapy
Personalized care
EXPERIMENTALPsychodynamic therapy or interactive guidance therapy
Interventions
Strategy based standard intregrative psychodynamic therapy
Eligibility Criteria
You may qualify if:
- Families who are requesting a consultation for functional or behavioural problems of their child
- Children under the age of 3
You may not qualify if:
- Parents suffering from a severe untreated psychiatric disorder
- Difficulties in speaking French
- Children with Autistic spectrum disorder
- Families already in care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
CHU de Besançon
Besançon, France
CHU de Montpellier
Montpellier, France
GHU Paris Psychiatrie et Neurosciences
Paris, France
CHU de Reims
Reims, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lauriane Coady-Vulliez, MD
CHU Besançon
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- 117 dyads will be enrolled
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2022
First Posted
January 25, 2022
Study Start
February 28, 2022
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share